| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/1381612043383331 |
| P698 | PubMed publication ID | 15544501 |
| P50 | author | Kumar Sambamurti | Q56642896 |
| P2093 | author name string | N H Greig | |
| D K Lahiri | |||
| J T Rogers | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 3111-3119 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents | |
| P478 | volume | 10 |
| Q39261947 | A novel 7-O-modified genistein derivative with acetylcholinesterase inhibitory effect, estrogenic activity and neuroprotective effect. |
| Q45560273 | Acetyl- and butyryl-cholinesterase inhibitory activities of the edible brown alga Eisenia bicyclis |
| Q45786493 | Acetylcholinesterase inhibition effects of marine fungi |
| Q37302845 | Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: implications for synaptic dysfunction and neuronal damage |
| Q53072962 | Beneficial Effects of Gagam-Palmultang on Scopolamine-Induced Memory Deficits in Mice. |
| Q64074408 | Curcumin-Loaded BSA Nanoparticles Protect More Efficiently Than Natural Curcumin Against Scopolamine-Induced Memory Retrieval Deficit |
| Q47878674 | Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease |
| Q36870079 | Environmental and dietary risk factors in Alzheimer's disease |
| Q46555006 | Genoprotective and neuroprotective effects of Daphne gnidium leaf methanol extract, tested on male mice |
| Q34797526 | Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model |
| Q38088283 | Huprines for Alzheimer's disease drug development |
| Q37029685 | Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine |
| Q27677846 | Kinetics of Torpedo californica acetylcholinesterase inhibition by bisnorcymserine and crystal structure of the complex with its leaving group |
| Q37440780 | Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. |
| Q36626374 | Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics |
| Q38914358 | Multifunctional activity of polyphenolic compounds associated with a potential for Alzheimer's disease therapy from Ecklonia cava |
| Q26825619 | N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease |
| Q46833725 | Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease |
| Q60957194 | Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases |
| Q30998627 | Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology |
| Q53347422 | Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway. |
| Q34743671 | Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis |
| Q48401878 | Toxicological effect of N, N, N', N'-tetramethylethylene on rat brain acetylcholinesterase |
| Q35671344 | Vanda roxburghii chloroform extract as a potential source of polyphenols with antioxidant and cholinesterase inhibitory activities: identification of a strong phenolic antioxidant |
Search more.